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ABSTRACT 
 
Human herpesvirus (HHV)-6B is a pathogen causing latent 
infection in virtually all humans. Nevertheless, the interaction 
of HHV-6B with its host cells is poorly understood. Although 
HHV-6B is approximately 90% homologous to HHV-6A, it 
expresses certain B-specific genes. In order to quantify the 
amount of expressed viral mRNA we have developed a method 
using real-time PCR on a LightCycler instrument. Here we 
describe an assay for the detection of the HHV-6B B6 mRNA, 
but our approach can easily be extended to involve other 
mRNAs. This method is useful during the study of HHV-6B 
biology and offers reliable and reproducible, quantitative 
detection of viral mRNA below the attomol range. 
 
INTRODUCTION 
 
In 1986, a novel virus was isolated from six 
immunocompromised patients by Salahuddin and co-workers 
and was denoted Human B-lymphotropic virus (HBLV) due to 
their capability to infect B cells (1). HBLV was shown to 
possess a double-stranded DNA genome consisting of more 
than 110 kbp and was identified as a member of the 
herpesvirus family (2). Later the virus was shown to have a 
broader host cell range with T cells as a major target and was 
renamed human herpesvirus 6 (HHV-6) (3,4). Based on 
differences in restriction enzyme cleavage patterns and 
different reactivity with monoclonal antibodies between 
different isolates, HHV-6 was divided into two subgroups, 
HHV-6A and HHV-6B. These viruses are two closely related 
betaherpesviruses with an overall nucleotide identity of 90% 
(5,6). Whereas more than 90% become seropositive to HHV-
6B in early childhood, the epidemiology of HHV-6A is less 
well characterized. Both HHV-6A and –6B infects T cells and 
monocytes  in vivo (7,8), but the viral gene expression from 
infected cells is only partially described. Since HHV-6A and –
6B may give rise to different types of infections and clinical 
outcomes, it is of interest to develop sensitive methods to 
distinguish between these viruses.  
 
PCR amplifications of reverse-transcribed RNA is a sensitive 
method for analyzing viral gene expression. However, 
conventional PCR is not quantitative, since the number of 
amplification cycles it takes before the amplified product 
reaches a plateau is not investigated. This contains the potential 
pitfall that samples with different amounts of template have 
reached the same plateau after 30 cycles, i.e., the same amount 
of amplified product, although the kinetics of the 
amplifications have been quite different. To avoid these 
problems, real-time PCR has been developed in order to 
monitor the amount of amplified product in each cycle. 
 
Recently, the genomes of HHV-6A and HHV-6B have been 
sequenced (5,6). Further studies have predicted 97 unique 
genes in HHV-6B, 88 of which have counterparts in HHV-6A 
(5). However, HHV-6A and HHV-6B each comprise nine 
genes, which are completely unique for each virus. The nine 
HHV-6B specific genes, designated B1-B9, provide nine 
obvious potential markers for HHV-6B infection.  
 
Using real-time PCR, we have recently characterized the 
expression patterns of approximately one third of the HHV-6B 
encoded genes with emphasis on their temporal expression (9). 
This analysis identified the expression of a number of 
previously predicted B-specific genes (5,9). To further quantify 
the amount of expressed mRNA we have developed a method 
using real-time PCR on a LightCycler instrument. This method 
is useful during the study of HHV-6B biology and offers 
reliable and reproducible detection of even small amounts of 
viral mRNA. Here the B6 transcript has been detected by real-
time PCR at different time points after infection. 
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MATERIALS AND METHODS 
Virus, cell culture, and T-cell infection 
 
The T-lymphoblastic cell line Molt-3 was infected by HHV-
6B, strain PL1 (generated by Dr. P. Lusso). Molt-3 T cells 
were grown at 37°C and 5% CO2 in Dulbecco’s Modified 
Eagle Medium (DMEM) supplemented with glutamine (0.292 
g/L), 10 mM HEPES, streptomycin (0.2 g/L), penicillin (0.2 
i.e./L), and 10% heat inactivated fetal bovine serum. Virus was 
collected from the supernatants of HHV-6B-infected T cells. 
The supernatants were cleared from cell debris by 
centrifugation at 4500 × g for 1 hour, and subsequently 
centrifuged at 100,000 × g for 1 hour. Infection was performed 
with 8×10
6 Molt-3 cells per ml of 20-fold concentrated virus 
supernatant.  
RNA purification 
 
Total RNA was isolated from 2×10
6 T cells at room 
temperature using High Pure RNA Isolation Kit (Roche 
Diagnostics Scandinavia AB, Hvidovre, Denmark). In brief, T 
cells were lysed in 4.5 M guanidine hydrochloride, 50 mM 
Tris-HCl and 30% Triton X-100 (w/v), pH 6.6, followed by the 
collection of nucleotides on a filter by high-speed 
centrifugation. To remove contaminating DNA, nucleotides 
were treated with 200 U DNase for 15 min and washed once in 
a buffer consisting of 5 M guanidine hydrochloride and 20 mM 
Tris HCl (pH 6.6) in ethanol, and twice in a buffer consisting 
of 20 mM NaCl and 2 mM Tris-HCl (pH 7.5) in ethanol. 
Finally, RNA was eluted in sterile, nuclease-free, double-
distilled H2O in a total volume of 60 µl. Total RNA 
concentration was determined in triplicates by absorbance 
measurements (GeneQuant II RNA/DNA Calculator, 
Pharmacia Biotech, Hørsholm, Denmark).  
Reverse transcription (RT)-PCR 
 
First-strand cDNA synthesis from 1 µg of total RNA was 
performed using 100 pmol of p(dT)15 primer for cDNA 
synthesis (Roche, Hvidovre, Denmark) followed by a 
denaturation step at 65°C for 10 min. The RNA was reverse 
transcribed using the method described by the manufacturer of 
the Expand Reverse Transcriptase kit for first-strand synthesis 
(Roche, Hvidovre, Denmark) for 45 min at 42°C. In brief, 1 × 
Expand Reverse Transcriptase buffer (first strand) was mixed 
with DTT in a final concentration of 10 mM, dNTP-mix, 
disodiumsalt solution with dATP, dCTP, dGTP, and dTTP at a 
final concentration of 1 mM, 20 U RNase inhibitor, and 50 U 
Expand Reverse Transcriptase enzyme. The reaction was 
stopped at 95°C for 2 minutes. The cDNA was diluted to 40 µl 
with double-distilled H2O. To avoid sample-to-sample 
contamination, separate laboratories were used for RNA 
purification, PCR set-up and template addition. 
Primers and probes 
 
Primers and probes for PCR amplification were designed by 
and purchased from TIB-MOLBIOL (Berlin, Germany). The 
primers for the internal standard β2-microglobulin were as 
follows: forward primer: CAA GCA GAG AAT GGA AAG 
TC; reverse primer: GAT GCT GCT TAC ATG TCT CG.  
 
The forward and reverse primers for the HHV-6B specific gene 
B6 are shown in Fig. 1 together with the specific internal 
probes B6 FL and B6 LC. The B6 FL probe was labeled at its 
3’-end with the donor dye, Fluorescein (FL) and the B6 LC 
probe was labeled at its 5’-end with the acceptor dye, 
LightCycler-Red 640 (LC Red 640).  
 
 
Fig. 1:  Location of primers and probes in B6 of HHV-6B. The entire ORF 
of B6, strain Z29 is shown (GenBank Accession number AF157706). The 
region spanning the two primers has been sequenced and found 100% identical 
between strain Z29 and strain PL1 [9]. B6 F, forward primer; B6 LC and B6 
FL, internal probe-pair; B6 R, reverse primer. 
Optimization of PCR conditions 
 
The concentration of the probe B6 LC was optimized with 0.2 
µM, 0.3 µM, and 0.4 µM. The annealing temperature was 
optimized with 55°, 57°, 60°, and 62°C and the MgCl2 
concentrations with 1, 2, 3, 4, and 5 mM.  
Real-time quantitative PCR 
 
Real-time PCR was carried out using the LightCycler – 
FastStart DNA Master Hybridization Probes reagent (Roche, 
Hvidovre, Denmark). A standard curve was created by 
amplifications of a synthetic oligonucleotide (DNA 
Technologies, Aarhus, Denmark) with the same sequence as 
the product amplified by B6F/B6R. For quantification, the test 
template used was cDNA derived from reverse transcribed 
RNA isolated 0h, 1h, 3h, 8h, 22h, and 48h after infection. H2O 
was included as a no template control, and cDNA derived from 
reverse transcribed RNA isolated from uninfected Molt-3 T 
cells as a negative control. The oligonucleotide standard was 
diluted in water in ten-fold dilutions over a range spanning the 
sample concentrations. To minimize variation between the 
oligonucleotide standard curve and the samples, due to the Øster and Höllsberg    90 
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presence of potential inhibitory factors in the samples, 5 µl of 
cDNA from non-infected Molt-3 T cells was added to each 
standard dilution. Oligonucleotide standard and cDNA were 
amplified in a mixture of 5 µl cDNA/diluted oligonucleotide 
standard, 2.5 mM MgCl2, 0.5 µM primer B6 F, 0.5 µM primer 
B6 R, 0.2 µM Probe B6 LC, 0.2 µM Probe B6 FL, and 2 µl 
LightCycler – FastStart DNA Master Hybridization Probes in a 
final volume of 20 µl. The PCR reaction was performed on a 
LightCycler instrument with 1 cycle of denaturation for 10 min 
at 95°C and 45 cycles of amplification at 95° for 10 sec, 60°C 
for 10 sec and 72°C for 5 sec. Cooling to 40°C took 30 sec. 
 
The log phase is used for quantification 
 
A PCR can be divided into three phases. The first is the 
background phase, which lasts until the signal of the amplified 
product exceeds the background signal. The second is the 
exponential growth phase (the log phase), which finally ends in 
the plateau phase. The plateau phase is reached if reaction by-
products accumulate and inhibit the reaction, if product re-
annealing takes over and starts competing with the 
hybridization of the primers, or if the enzyme is heat-
inactivated over time and thereby becomes limiting (10). The 
amount of product can be determined from the log phase. In the 
log phase the amount of product increases logarithmically with 
a maximal efficiency of 2 and a minimum efficiency of 1. The 
number of cycles required to produce a signal above 
background fluorescence can be converted to the starting 
concentration of the unknowns from the standard curve. The 
crossing point value (Cp) is the point where the log line 
intersects a horizontal threshold line (discarding background 
fluorescence). The amount of target is the same in all samples 
at this point of intersection (10). The amplification course of 
the log phase is described by the following equation: 
 
Tn=T0 (E)
n (1) 
 
Where Tn is the amount of target at n cycles, T0 the initial 
amount of target, and E the efficiency of amplification (10). If 
the copy number of target at the crossing point is K, and the 
cycle number to obtain K is Cp, then by equation 1: 
 
K=T0 (E)
Cp   (2)    Ù    logK=log T0 + Cp logE     (3) 
 
Cp is the value measured and T0 the initial concentration of the 
standard determined by the investigator. Rearranging to the 
form y=ax+b gives: 
 
Cp=-(1/logE) log T0 + (logK/logE)     (4) 
 
The standard curve is described by this equation with the log of 
the initial template copy number plotted horizontally and the 
cycle number at the crossing point vertically. By equation 4: 
 
Slope=-1/logE (5) Ù logE = -1/Slope (6) Ù E=10
-1/Slope     (7) 
 
Where E is the efficiency and “Slope” is the slope of the 
standard curve. To obtain reliable results it is important to 
achieve equivalent PCR efficiencies for the standard curve and 
the samples. The sample efficiency was determined in a series 
of template dilutions.  
RESULTS AND DISCUSSION 
 
The  β2-microglobulin values were highly 
reproducible 
 
The reproducibility of the method used for the initial detection 
of the HHV-6B-specific transcript B6 was determined in three 
independent but identical experiments using internal control-
primers for β2-microglobulin. In each experiment, the relative 
amount of β2-microglobulin was determined with 13 separate 
measurements on each cDNA from infected T cells (Fig. 2).  
 
 
Fig. 2: Reproducibility of internal control. As an internal control, β2-
microglobulin was amplified in three independent but identical experiments 
with 13 separate measurements on each cDNA. The number of cycles (Cp) 
demanded to amplify the initial amount of target above background is used as a 
measure for the relative amount of target. The standard deviation is indicated 
on each bar. 
 
The determination by real-time PCR with β2-microglobulin as 
an internal control was highly reproducible. In addition, when 
comparing the amount of β2-microglobulin in uninfected cells 
with the amount found in infected cells, no difference was 
observed (data not shown). 
 
In conclusion, β2-microglobulin turned out to be useful as an 
internal control, since the values at all times were highly 
reproducible, and since the cellular expression level apparently 
was unaffected by the HHV-6B infection. Øster and Höllsberg    91 
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Optimal PCR conditions 
 
Matrix experiments to systematically define the optimal 
conditions for two primers and two probes with respect to 
concentrations, temperatures and MgCl2 will define the best 
conditions for the reactions. However, such experiments are 
large and fairly expensive. We have had success with an 
approach where our primers are designed with an expected 
annealing temperature around 60°C. Of notice, the 
concentration of MgCl2 in real-time PCR using the LightCycler 
technology is higher than that used in conventional PCR. The 
probes designed by TIB MOLBIOL (Berlin, Germany) are 
carefully selected to have similar characteristics. For practical 
purposes we chose to optimize on only one of the probes. For 
the quantification of B6, we found the optimal conditions to be 
0.2 µM probe B6 LC, the annealing temperature 60°C and 4.5 
mM MgCl2. 
Similar PCR efficiencies were obtained 
 
The efficiency is obtained by plotting the crossing point (Cp) 
values against the log of the initial template concentration (Fig. 
3). Sample and standard efficiencies are equal if they have the 
same slope. In addition, they should be constant over the 
concentration range studied, that is, linearity should be 
obtained on semi-log plots.  
 
 
Fig. 3: PCR amplification efficiency. The crossing point (Cp) values plotted 
against the log of the initial template concentrations. From the formula E = 10
-
1/Slope the efficiency is calculated to 2.0, in that the slope of the line is -3.304. 
 
As shown in Fig. 3, the efficiency of the standard amplification 
was found to be constant over the concentration range studied. 
That is, linear plots were obtained with an efficiency of 2.0, 
indicating an exponential increase of the product. Likewise, a 
linear plot with a comparable efficiency was obtained in a 
number of sample dilutions (data not shown). 
 
Viral mRNA can be detected in attomol amounts 
 
In initial experiments, the relative amount of the HHV-6B-
specific transcript B6 was determined at 0h, 1h, 3h, 8h, 22h, 
and 48h after infection (Fig. 4). Surprisingly transcripts could 
be detected as early as 1h after infection. Based on further 
experiments (9) B6 was characterized as belonging to the 
group of genes expressed immediately after infection. As can 
be seen from Fig. 4, the increase in mRNA amount is 
pronounced early after infection. 
 
 
Fig. 4: Detection of B6 mRNA. The relative amount of B6 mRNA was 
determined at the indicated time points after infection. The amount of β2-
microglobulin was constant in all test materials whereas the amount of B6 
mRNA increased over time. 
 
To make a relative quantification of the transcripts, specific 
probes were designed for B6 (Fig. 1) in addition to a synthetic 
oligonucleotide encompassing the B6 primers annealing sites. 
The quantification was performed in two separate experiments 
with separately prepared standard curves but with the same 
batch of samples. Concentrations were reproducibly 
determined below the attomol range in duplicate experiments 
(Table 1).  
 
Table 1: Quantification of the amount of B6 mRNA 
present per ng total RNA at different time points 
following HHV-6B (PL1) infection of Molt-3 cells. 
B6 (10
-21 mol/ng RNA)  Template 
 
Exp. 1 
 
Exp. 2 
 
Mean 
Mean copy 
number/ng 
RNA 
Uninfected cells  0.00  0.00  0.00  0 
cDNA 1 h  0.19  0.15  0.17  106 
cDNA 3 h  13.7  23.7  18.7  11,650 
cDNA 8 h  276  196  236  147,028 
cDNA 22 h  589  608  598  372,554 
cDNA 48 h  696  568  632  393,736 
No template control  0.00  0.00  0.00  0 
 
Thus, this method possesses the advantages of being fast, 
sensitive, and highly reproducible. These features may be of 
special interest when studying low-level HHV-6B expression 
in latently infected cells. In addition, it can be used for DNA 
quantification in different specimens, including its application Øster and Höllsberg    92 
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as a novel sensitive measurement of virus titers in supernatants, 
an approach that would be faster and more specific than the 
conventional read-out of cytopathic effects in cell culture 
systems. 
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PROTOCOLS 
 
Cell culture, virus, and T-cell infection 
 
1.  Grow Molt-3 T cells in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% heat inactivated fetal 
bovine serum, glutamine (0.292 g/L), 10 mM HEPES, streptomycin (0.2 g/L), and penicillin (0.2 i.e./L) at 0.6×10
6 Molt-3 
T cells/ml. 
2. Resuspend  8×10
6 Molt-3 T cells per ml virus (HHV-6B) supernatant. 
3.  Dilute the infected cells to 4×10
6 cells/ml with supplemented DMEM. 
4.  Expand with fresh supplemented DMEM when needed (if the medium changes color from red to orange/dark yellow). 
5.  Isolate RNA at the preferred time points after infection from 2×10
6 infected Molt-3 T cells using High Pure RNA 
Isolation Kit (Roche Diagnostics Scandinavia AB, Hvidovre Denmark) as described by the manufacturer. 
6.  Determine the concentration of total RNA by absorbance measurements. 
 
cDNA synthesis 
 
1.  Mix 1 µg of total RNA with 100 pmol of p(dT)15 primer for cDNA synthesis (Roche, Hvidovre, Denmark).  
2.  Denature the RNA at 65°C for 10 min. Put on ice immediately after. 
3.  Prepare a mixture of 1 × Expand Reverse Transcriptase buffer (first strand), DTT in a final concentration of 10 mM, 
dNTP-mix, disodiumsalt solution with dATP, dCTP, dGTP, and dTTP at a final concentration of 1 mM, 20 U RNase 
inhibitor, and 50 U Expand Reverse Transcriptase enzyme. 
4.  Add the nucleotide/buffer/enzyme mixture to each tube containing denatured total RNA and p(dT)15 primer in a final 
volume of 20 µl. 
5.  Incubate the tubes at 42°C for 45 min. 
6.  Stop the reaction at 95°C for 2 minutes.  
7.  Put on ice and freeze at –70°C. 
 
Quantitative real-time PCR 
 
1. Optimize  MgCl2 concentration, annealing temperature, and amount of target. 
2.  Dilute the standard (synthetic oligonucleotide or cloned fragment) in water in ten-fold dilutions in a range spanning the 
sample concentrations immediately before use. Keep the dilutions on ice. 
3.  Prepare a reaction mixture for all samples containing all ingredients (except from the template) with 2.5 mM MgCl2, 0.5 
µM forward primer, 0.5 µM reverse primer, 0.2 µM Probe LC Red, 0.2 µM Probe FL, and 2 µl LightCycler – FastStart 
DNA Master Hybridization Probes. 
4.  Mix 5 µl of each cDNA/diluted oligonucleotide with 15 µl reaction mixture immediately before analysis. 
5.  Perform the PCR reation on a LightCycler instrument with 1 cycle of denaturation for 10 min at 95°C and 45 cycles of 
amplification at 95° for 10 sec, 60°C for 10 sec and 72°C for 5 sec. Finally, cooling to 40°C for 30 sec. 